Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment completed in pivotal DERBY and OAKS studies of pegcetacoplan

July 8, 2020

ImmuneOnco Biopharmaceuticals divulges anti-PD-L1 and anti-VEGF compounds

July 8, 2020

RemeGen describes new angiogenesis inhibitors

July 8, 2020

Prelude Therapeutics discloses Mcl-1 inhibitors

July 8, 2020

Theravance Biopharma patents TGFR-1 inhibitors

July 8, 2020

Dana-Farber Cancer Institute presents new MAPK9 inhibitors

July 8, 2020

ImmunoGen presents next-generation FR-alpha-targeting ADC, IMGN-151

July 8, 2020

Discovery of novel HDAC6 selective inhibitors with potent preclinical activity

July 8, 2020

Topline data presented from global phase II trial of SEP-4199 in bipolar I depression

July 8, 2020

Good vs. evil in the synovial joint

July 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...